跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLICLADA MODIFIED-RELEASE TABLETS 60MG - HSA Drug Approval Details
Approvals
/
HSA
/
GLICLADA MODIFIED-RELEASE TABLETS 60MG
Approved
THERAPEUTIC
GLICLADA MODIFIED-RELEASE TABLETS 60MG
KRKA, D.D., NOVO MESTO (SLOVENIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 2, 2017
Approval ID
6ff3cadee5e06300
Company
KRKA, D.D., NOVO MESTO (SLOVENIA)
Type
Therapeutic
Approval Details
Approval Id
6ff3cadee5e06300
Drug Name
GLICLADA MODIFIED-RELEASE TABLETS 60MG
Product Name
GLICLADA MODIFIED-RELEASE TABLETS 60MG
Approval Number
SIN15253P
Approval Date
2017-06-02
Registrant
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
A10BB09
Atc Item Name
gliclazide
Pharma Manufacturer Name
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
Gliclazide
60.00mg
GLICLAZIDE
60 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 2, 2017
Approval ID
6ff3cadee5e06300
Type
Therapeutic
Back to HSA Approvals